Lifelong learning is no longer optional — it’s essential. But who has the time and resources to go back to school? The ...
Dr. Erin Bass says the program looks for key words and skills that come up in multiple job descriptions. The program's latest ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
Investment in the logistics sector during the Tenth Five-Year Plan increased to around RO3.4 billion, it was revealed at the ...
Bernhardt said community policing will remain a priority in 2026. The Community Affairs Unit will continue building ...
25mon MSN
Immunic (IMUX) reviews 2025 performance and highlights upcoming milestones, shares up 24.10%
Immunic, Inc. (NASDAQ:IMUX) is one of the stocks under $1 that will explode. Immunic, Inc. (NASDAQ:IMUX) has recently ...
Digital Insurance contacted insurance professionals to comment on workers' compensation insurance predictions for 2026. Your ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
21h
Muze Health Launches Verify Muze, a Comprehensive Software Platform for Medicaid Work Requirements
The human-centered, AI-driven platform enables Medicaid members and administrators to meet H.R.1 work and community ...
SwineTech co-founder Matthew Rooda recalls how he blended animal agriculture and health care technology to reduce piglet ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback